Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma

Molecular Membrane Biology

Volumn 28, Issue 3, 2011, Pages 182-186

  Amann, Thomas ^a   Kirovski, Georgi ^a   Bosserhoff, Anja Kathrin ^b   Hellerbrand, Claus ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

GLUT1; HCC; hepatocellular carcinoma; polymorphism

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; SLC2A1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER STAGING; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GROWTH; GENETIC POLYMORPHISM; GENETICS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER TUMOR; MIDDLE AGED; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TISSUE MICROARRAY;

CARCINOMA, HEPATOCELLULAR; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS, GENETIC; TISSUE ARRAY ANALYSIS;

EID: 79953174269     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.3109/09687688.2011.554447     Document Type: Article

References (13)

1. Amann T, Hellerbrand C. 2009. GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets 13(12):1411-1427.
2. Amann T, Maegdefrau U, Hartmann A, Agaimy A, Marienhagen J, Weiss TS, Stoeltzing O, Warnecke C, Scholmerich J, Oefner PJ, Kreutz M, Bosserhoff AK, Hellerbrand C. 2009. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol 174(4): 1544-1552.
3. Brahimi-Horn MC, Chiche J, Pouyssegur J. 2007. Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 19(2):223-229. (Pubitemid 46386401)
4. Bruix J, Boix L, Sala M, Llovet JM. 2004. Focus on hepatocellular carcinoma. Cancer Cell 5(3):215-219. (Pubitemid 38402113)
5. Cooper R, Sarioglu S, Sokmen S, Fuzun M, Kupelioglu A, Valentine H, Gorken IB, Airley R, West C. 2003. Glucose transporter-1 (GLUT-1): A potential marker of prognosis in rectal carcinoma? Br J Cancer 89(5):870-876. (Pubitemid 37175810)
6. Farazi PA, DePinho RA. 2006. Hepatocellular carcinoma patho-genesis: From genes to environment. Nat Rev Cancer 6(9): 674-687. (Pubitemid 44286000)
7. Hellerbrand C, Amann T, Schlegel J, Wild P, Bataille F, Spruss T, Hartmann A, Bosserhoff AK. 2008. The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma. Gut 57(2):243-251. (Pubitemid 351158054)
8. Hodgkinson AD, Page T, Millward BA, Demaine AG. 2005. A novel polymorphism in the 5¢ flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus. J Diabetes Complic 19(2):65-69a.
9. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. 2008. Cancer statistics, 2008. CA Cancer J Clin 58(2):71-96. (Pubitemid 351521864)
10. Kim JW, Dang CV. 2006. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 66(18):8927-8930. (Pubitemid 44521105)
11. Muhlbauer M, Bosserhoff AK, Hartmann A, Thasler WE, Weiss TS, Herfarth H, Lock G, Scholmerich J, Hellerbrand C. 2003. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 125(4):1085-1093. (Pubitemid 37193455)
12. Oliver RJ, Woodwards RT, Sloan P, Thakker NS, Stratford IJ, Airley RE. 2004. Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Transla-tional Research Fund studies. Eur J Cancer 40(4): 503-507. (Pubitemid 38220765)
13. Page T, Hodgkinson AD, Ollerenshaw M, Hammonds JC, Demaine AG. 2005. Glucose transporter polymorphisms are associated with clear-cell renal carcinoma. Cancer Genet Cytogenet 163(2):151-155. (Pubitemid 41760412)